#FLAURA2 analysis of CTDNA analysis @dplanchard #ESMO26
• baseline detected plasma EGFRm correlated with shorter PFS
15 浏览 · 0 赞 · 0 转发 · 1 回复
Improving prevention of moderate to severe dermatologic adverse events in EGFR-mutant advanced NSCLC treated with first-line (1L) subcutaneous (SC) amivantamab + lazertinib: First results from a new COCOON cohort
https://esmocongress.esmo.orgExtended circulating tumor DNA (ctDNA) sequencing to optimize the selection between anti-EGFR rechallenge and other later lines in patients with RAS/BRAF wild-type metastatic colorectal cancer
https://esmocongress.esmo.org- **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
https://esmocongress.esmo.org- Kenn Samala@KSamalaMD
@dplanchard • plasma EGFR clearance was prognostic but not predictive • combi tx > osi mono regardless of plasma EGFR clearance status #ESMO26
来源：Kenn Samala · x.com